#Germany #Berlin #Lung Cancer #Coreline Soft #Charité Berlin

Coreline Soft's Groundbreaking AI Solution at Charité Berlin

In a significant leap forward for medical technology, Coreline Soft, a frontrunner in medical artificial intelligence, has successfully deployed its latest lung cancer screening (LCS) solution at Charité – Universitätsmedizin Berlin, Germany's largest university hospital. This pivotal move marks an entry into a central hub for national lung cancer screening in the country.

The Charité hospital is renowned globally, ranked 7th by Newsweek in 2025, and serves as a public institution collaboratively managed by federal and state authorities in Berlin. It is considered a benchmark institution for national health policies and clinical guidelines.

Key Highlights of the Implementation

• - Product Focus: The core product, AVIEW LCS Plus, is specifically designed for lung cancer detection using low-dose computed tomography (LDCT). This advanced technology allows for highly efficient cancer screenings, addressing a critical need in early detection.
• - Integrated Analysis Functionality: One of the standout features is its capability to automatically analyze pulmonary nodules, chronic obstructive pulmonary disease (COPD), and coronary artery calcification (CAC) from a single CT scan. This creates not only efficiency but also consistency in findings.
• - Proven Reliability: Before its current deployment, the solution was validated within the framework of the HANSE project, a national lung cancer screening pilot initiative in Germany, exhibiting stable performance across multi-center environments.

A Strategic Shift in the Screening Landscape

Germany is at a crucial juncture, transitioning from pilot programs to establishing a formal national LCS framework. The Gemeinsame Bundesausschuss (G-BA) is expected to include LDCT-based screenings into the statutory health insurance catalog in the first half of this year. Consequently, the market is shifting towards standardized processes that encompass participant screenings, dual readings, follow-ups, and quality control, moving beyond individual hospital implementations.

To meet rigorous requirements such as dual reading protocols and data pseudonymization, Coreline Soft has introduced AVIEW HUB, which serves as a central platform for multi-center screening operations. This innovative platform integrates quality control functionalities while ensuring regulatory compliance and reducing the manual workload for healthcare professionals.

Coreline Soft's Competitive Edge

Industry experts view Coreline’s implementation at Charité as a clear indicator of a transformative moment, shifting focus from product performance to competition over screening infrastructure. With the establishment of national reimbursement models and standardized processes, it is anticipated that companies proficient in multi-center operations and hub-based management will enhance their global competitiveness. Coreline Soft, with its robust experience and strategic planning, is well-positioned to leverage these changes for greater long-term success in the healthcare sector.

As the landscape of lung cancer screening evolves, the combination of AI technology and institutional support at Charité stands to dramatically improve patient outcomes in lung cancer detection across Germany and beyond.